In the new All Wales Medicines Strategy Group (AWMSG) annual report, read an overview of 2020-2021 and how AWMSG and the All Wales Therapeutics and Toxicology Centre (AWTTC) responded to the challenges of the pandemic and supported the safe and prudent prescribing of medicines.
At the beginning of April 2020, the COVID-19 pandemic was escalating and the decision was made to suspend the normal business of the AWMSG and its sub-groups. This was so that members of the Committee, many of whom are frontline staff, could focus on the care of patients and delivery of key messages.
This report highlights the many achievements of AWMSG over the last year, despite the difficulties caused by the pandemic. As we start to see the easing of restrictions and, hopefully, a return to normality, AWMSG will continue to support Welsh Government, patients and NHS colleagues in the recovery phase.
Professor Ceri Phillips took up a new role as Vice Chair of Cardiff and Vale University Health Board and his tenure as Chair of AWMSG ended in March 2021.
He says, "It has been a privilege and pleasure to see AWMSG ‘come of age’ in October 2020 and to be able to share in some of its achievements over the 18 years, both as a Committee member and as the Chair. I will continue to follow the progress of the group as it continues to mature and play an increasingly significant role in the recovery phase of the NHS over the next few years."
Read the full 2020-2021 AWMSG Annual Report